YUCAIPA, Calif., April 12, 2011 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an ISO 13485:2003 certified medical device manufacturer of patented and proprietary respiratory medical devices announced today that the company has been approved to sell medical product through the Defense Acquisition Program Administration effective May 1, 2011; associated DAPA number SPO200-11-H-0041.
"On April 6, 2011 I received approval from the Defense Acquisition Program Administration to sell our product to their facilities worldwide. I am confident, along with our management, that our Oxyview and Smart Nasal Cannula will be a successful medical technology for the clinicians and patients in need of oxygen delivery at various military facilities. I expect to make an announcement as revenues increase with Military sales," stated Gary B. Tilden, Chairman and Chief Operations Officer. From June through September, 2010 the company's military consultant, KGMA Business Solutions, introduced the products to various military bases in the US. There was strong interest in purchasing Ingen's Oxyview and Smart Nasal Cannula for their respiratory needs.
The Defense Acquisition Program Administration (DAPA) was launched on January 2, 2006 as a streamlined military procurement agency, replacing the former Defense Procurement Agency (DPA). DAPA is responsible for defense industry equipment purchases. The new agency was formed in order to ensure transparency in the defense procurement process and consolidates eight organizations that were responsible for procurement and the development of technology that were formerly under the purview of the Ministry of National Defense and the separate military services.
About Ingen:
The Public Company's wholly owned subsidiary is an established ISO certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. Visit .
The Ingen Technologies, Inc. logo is available at
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Gary Tilden, Chairman 909-790-7180 www.INGEN-TECH.COM info@ingen-tech.com
